Castle Biosciences
CSTL
CSTL
174 hedge funds and large institutions have $1.46B invested in Castle Biosciences in 2021 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 73 increasing their positions, 53 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
4.69% more ownership
Funds ownership: 80.7% → 85.38% (+4.7%)
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
80% less call options, than puts
Call options by funds: $2.37M | Put options by funds: $12.1M
Holders
174
Holding in Top 10
2
Calls
$2.37M
Puts
$12.1M
Top Buyers
| 1 | +$36.2M | |
| 2 | +$24.7M | |
| 3 | +$20.3M | |
| 4 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$19.8M |
| 5 |
ZCI
Zevenbergen Capital Investments
Edmonds,
Washington
|
+$19M |
Top Sellers
| 1 | -$17M | |
| 2 | -$16M | |
| 3 | -$10.1M | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$9.37M |
| 5 |
RI
Redwood Investments
Boston,
Massachusetts
|
-$8.66M |